Ascrinvacumab (PF-03446962) is a monoclonal antibody designed for the treatment of cancer.
This drug was developed by Pfizer Inc.
References




Ascrinvacumab (PF-03446962) is a monoclonal antibody designed for the treatment of cancer.
This drug was developed by Pfizer Inc.



